Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline Consumer Healthcare
980 Great West Road, Brentford, Middlesex, TW8 9GS
Telephone: +44 (0)20 8047 5000
Medical Information Direct Line: +44 (0)20 8047 2500
Medical Information e-mail: customer.relations@gsk.com
Customer Care direct line: +44 (0)20 8047 2700
Medical Information Fax: +44 (0)20 8047 6860

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 08/01/2010
SPC Piriteze Allergy Tablets (P)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/01/2010 and displayed until Current
Reasons for adding or updating:
  • Extra statutory information
Date of revision of text on the SPC:   24-Nov-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


The SPC for Piriteze (P) has been updated to  align with Article 30 harmonisation referral for Zyrtec.

Updated on 22/06/2009 and displayed until 08/01/2010
Reasons for adding or updating:
  • Extra statutory information
Date of revision of text on the SPC:   17-Mar-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
The licence now has unlimited expiry.
Updated on 15/05/2008 and displayed until 22/06/2009
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   04-Apr-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
In section 6.5 (nature and contents of container), the 7 pack size has been removed
Updated on 22/10/2007 and displayed until 15/05/2008
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   10/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.1 Addition of "in adults and children aged 6 years and over"
Section 4.2 Dosing changed from adults and children over 12 to adults and children aged 6 years and over.  Addition of statement "Not for use by children under 6 years of age"
Section 10 Updated
Updated on 19/06/2007 and displayed until 22/10/2007
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
  cetirizine hydrochloride